Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.
2.

Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System.

Nakajima S, Watashi K, Ohashi H, Kamisuki S, Izaguirre-Carbonell J, Kwon AT, Suzuki H, Kataoka M, Tsukuda S, Okada M, Moi ML, Takeuchi T, Arita M, Suzuki R, Aizaki H, Kato T, Suzuki T, Hasegawa H, Takasaki T, Sugawara F, Wakita T.

J Virol. 2016 Sep 29;90(20):9058-74. doi: 10.1128/JVI.00856-16. Print 2016 Oct 15.

3.

Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes.

Schupp AK, Trilling M, Rattay S, Le-Trilling VT, Haselow K, Stindt J, Zimmermann A, Häussinger D, Hengel H, Graf D.

J Virol. 2016 Jul 11;90(15):6686-98. doi: 10.1128/JVI.00299-16. Print 2016 Aug 1.

4.

The crucial role of bile acids in the entry of porcine enteric calicivirus.

Shivanna V, Kim Y, Chang KO.

Virology. 2014 May;456-457:268-78. doi: 10.1016/j.virol.2014.04.002. Epub 2014 Apr 19.

5.

Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease.

Smalling RL, Delker DA, Zhang Y, Nieto N, McGuiness MS, Liu S, Friedman SL, Hagedorn CH, Wang L.

Am J Physiol Gastrointest Liver Physiol. 2013 Sep 1;305(5):G364-74. doi: 10.1152/ajpgi.00077.2013. Epub 2013 Jun 27.

6.

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.

Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C.

Viruses. 2013 May 23;5(5):1292-324. doi: 10.3390/v5051292. Review.

7.

Host genetic variants in the pathogenesis of hepatitis C.

Rau M, Baur K, Geier A.

Viruses. 2012 Dec;4(12):3281-302. Review.

8.

A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population.

Müllenbach R, Weber SN, Krawczyk M, Zimmer V, Sarrazin C, Lammert F, Grünhage F.

BMC Gastroenterol. 2012 Jun 8;12:63.

9.

Bile acids specifically increase hepatitis C virus RNA-replication.

Chhatwal P, Bankwitz D, Gentzsch J, Frentzen A, Schult P, Lohmann V, Pietschmann T.

PLoS One. 2012;7(4):e36029. doi: 10.1371/journal.pone.0036029. Epub 2012 Apr 25.

10.

Nuclear receptor variants in liver disease.

Müllenbach R, Weber SN, Lammert F.

J Lipids. 2012;2012:934707. doi: 10.1155/2012/934707. Epub 2011 Dec 21.

11.

Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.

Wu C, Gilroy R, Taylor R, Olyaee M, Abdulkarim B, Forster J, O'Neil M, Damjanov I, Wan YJ.

Hepatology. 2011 Dec;54(6):1966-74. doi: 10.1002/hep.24645.

12.

The interaction between HCV and nuclear receptor-mediated pathways.

Raglow Z, Thoma-Perry C, Gilroy R, Wan YJ.

Pharmacol Ther. 2011 Oct;132(1):30-8. doi: 10.1016/j.pharmthera.2011.05.005. Epub 2011 May 18. Review.

13.

Bile acids promote HCV replication through the EGFR/ERK pathway in replicon-harboring cells.

Patton JB, George D, Chang KO.

Intervirology. 2011;54(6):339-48. doi: 10.1159/000321452. Epub 2011 Feb 5.

14.

A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Chockalingam K, Simeon RL, Rice CM, Chen Z.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3764-9. doi: 10.1073/pnas.0915117107. Epub 2010 Feb 8.

15.

Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Zollner G, Trauner M.

Br J Pharmacol. 2009 Jan;156(1):7-27. doi: 10.1111/j.1476-5381.2008.00030.x. Review.

16.

Transactivation of the hepatitis B virus core promoter by the nuclear receptor FXRalpha.

Ramière C, Scholtès C, Diaz O, Icard V, Perrin-Cocon L, Trabaud MA, Lotteau V, André P.

J Virol. 2008 Nov;82(21):10832-40. doi: 10.1128/JVI.00883-08. Epub 2008 Sep 3.

Supplemental Content

Support Center